• Product name
    Anti-ENAH antibody [EPR5660]
    See all ENAH primary antibodies
  • Description
    Rabbit monoclonal [EPR5660] to ENAH
  • Tested applications
    Suitable for: WB, IHC-P, Flow Cytmore details
    Unsuitable for: ICC or IP
  • Species reactivity
    Reacts with: Mouse, Human
    Does not react with: Rat
  • Immunogen

    Synthetic peptide corresponding to a sequence within Human ENAH (Q8N8S7).

  • Positive control
    • MDA-MB-435, MCF7, HUVEC and A431 cell lysates; Human Uterus tissue.
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.



Our Abpromise guarantee covers the use of ab124685 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Detects a band of approximately 80 kDa (predicted molecular weight: 67 kDa).
IHC-P 1/500 - 1/1000. Antigen rerieval is recommended.
Flow Cyt 1/100 - 1/500. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
  • Application notes
    Is unsuitable for ICC or IP.
  • Target

    • Function
      Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation. Required for the actin-based mobility of Listeria monocytogenes.
    • Tissue specificity
      Expressed in myoepithelia of parotid, breast, bronchial glands and sweat glands. Expressed in colon-rectum muscolaris mucosae epithelium, pancreas acinar ductal epithelium, endometrium epithelium, prostate fibromuscolar stroma and placenta vascular media. Overexpressed in a majority of breast cancer cell lines and primary breast tumor lesions.
    • Sequence similarities
      Belongs to the Ena/VASP family.
      Contains 1 WH1 domain.
    • Domain
      The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization.
    • Post-translational
      NTN1-induced PKA phosphorylation on Ser-265 directly parallels the formation of filopodial protrusions.
      Phosphorylated upon DNA damage, probably by ATM or ATR.
    • Cellular localization
      Cytoplasm. Cytoplasm > cytoskeleton. Cell projection > lamellipodium. Cell projection > filopodium. Cell junction > synapse. Cell junction > focal adhesion. Targeted to the leading edge of lamellipodia and filopodia by MRL family members. Colocalizes at filopodial tips with a number of other proteins including vinculin and zyxlin. Colocalizes with N-WASP at the leading edge. Colocalizes with GPHN and PFN at synapses.
    • Information by UniProt
    • Database links
    • Alternative names
      • ENA antibody
      • Enah antibody
      • ENAH_HUMAN antibody
      • MENA antibody
      • NDPP1 antibody
      • Protein enabled homolog antibody
      see all

    Anti-ENAH antibody [EPR5660] images

    • ab124685, at 1/500 dilution, staining ENAH in formalin-fixed, paraffin-embedded Human uterus tissue, by Immunohistochemistry.
    • All lanes : Anti-ENAH antibody [EPR5660] (ab124685) at 1/1000 dilution

      Lane 1 : MDA-MB-435 cell lysate
      Lane 2 : MCF7 cell lysate
      Lane 3 : HUVEC cell lysate
      Lane 4 : A431 cell lysate

      Lysates/proteins at 10 µg per lane.

      Goat anti-rabbit HRP at 1/2000 dilution

      Predicted band size : 67 kDa
      Observed band size : 80 kDa (why is the actual band size different from the predicted?)

    References for Anti-ENAH antibody [EPR5660] (ab124685)

    This product has been referenced in:
    • Li CF  et al. Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics. Clin Cancer Res 18:1598-610 (2012). Read more (PubMed: 22322669) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab124685.
    Please use the links above to contact us or submit feedback about this product.


    Sign up